Anvia Therapeutics is developing small molecule inhibitors against clinically validated targets to expand treatment options for patients suffering from inflammatory and autoimmune diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- New York, Ny, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.anviatx.com/
- Keywords
- New York.
- HQ
- New York, NY
Anvia Therapeutics Questions
Anvia Therapeutics's website is https://www.anviatx.com/
Anvia Therapeutics's LinkedIn profile is https://www.linkedin.com/company/anvia-therapeutics
Anvia Therapeutics has
6 employees.
View email and phone details for 6
employees at Anvia Therapeutics.
Anvia Therapeutics's industry is
Biotechnology Research
Anvia Therapeutics's top competitors are
Eli Lilly And Company,
Stealth Biotech,
Volastra Therapeutics,
Deerfield Management,
Alloy Therapeutics, Inc.,
Bluerock Therapeutics,
Regeneron,
Immunai,
Eikon Therapeutics.
Anvia Therapeutics's categories are Biotechnology Research
Anvia Therapeutics's founding year is 2024
